Journal of the American Academy of Dermatology
Volume 62, Issue 2 , Pages 205-217, February 2010

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial

Presented at the 2008 Conference of the American Academy of Dermatology, San Antonio, TX, March 2008; the 2009 Conference of the American Academy of Dermatology, San Francisco, CA, March 2009; and the 2007 Annual Conference of the British Association of Dermatologists, Birmingham, UK, June 2007.

  • Annika Grant, RN

      Affiliations

    • Florida Academic Dermatology Centers, Miami, Florida
    • ,
  • Tayler Gonzalez, PharmD

      Affiliations

    • Centocor Inc, Horsham, Pennsylvania
    • ,
  • Michael O. Montgomery, MD

      Affiliations

    • Centocor Inc, Horsham, Pennsylvania
    • ,
  • Vanessa Cardenas

      Affiliations

    • Florida Academic Dermatology Centers, Miami, Florida
    • ,
  • Francisco A. Kerdel, MBBS

      Affiliations

    • Florida Academic Dermatology Centers, Miami, Florida
    • Corresponding Author InformationReprint requests: Francisco A. Kerdel, MBBS, Florida Academic Dermatology Centers, 1400 NW 12 St, Suite 4, Miami FL 33136.

Accepted 10 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by Centocor Inc.

 Disclosure: Dr Kerdel, Ms Grant, and Ms Cardenas have received research support from Centocor Inc. Drs Gonzalez and Montgomery are employees of Centocor Inc.

PII: S0190-9622(09)00782-8

doi:10.1016/j.jaad.2009.06.050

Journal of the American Academy of Dermatology
Volume 62, Issue 2 , Pages 205-217, February 2010

Article Tools

* Image Usage & Resolution